[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-367446-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-367446-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","animal-models-in-preclinical-metastatic-breast-cancer-immunotherapy-research-a-systematic-review-and-meta-analysis-of-efficacy-outcomes","Animal models in preclinical metastatic breast cancer immunotherapy research - A systematic review and meta-analysis of efficacy outcomes","","Breast cancer, especially metastatic breast cancer (MBC), creates aggressive clinical challenges with limited treatment success. Immunotherapy shows promise, but differences between preclinical animal models and human disease hinder translation. This systematic review and meta-analysis quantified immunotherapy effects on primary and metastatic tumor regression in animal MBC models and appraised model suitability and reproducibility. Using a preregistered PROSPERO protocol, searches identified 2255 studies and 108 were included.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/animal-models-in-preclinical-metastatic-breast-cancer-immunotherapy-research-a-systematic-review-and-meta-analysis-of-efficacy-outcomes/367446/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/animal-models-in-preclinical-metastatic-breast-cancer-immunotherapy-research-a-systematic-review-and-meta-analysis-of-efficacy-outcomes/367446.png","ImageObject",300,407,{"name":42,"@type":43},"Maya Linwood","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-07","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the purpose of this systematic review and meta-analysis?","Question",{"text":63,"@type":64},"To evaluate how immunotherapy affects primary and metastatic tumor regression in animal models of metastatic breast cancer, and to assess model appropriateness and reproducibility for improving future preclinical study design.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which databases and study numbers were used in the review?",{"text":68,"@type":64},"Searches were conducted in MEDLINE, Embase, and Web of Science, yielding 2255 studies for title/abstract screening and 108 studies after full-text screening.",{"name":70,"@type":61,"acceptedAnswer":71},"What did the meta-analysis find about immunotherapy efficacy?",{"text":72,"@type":64},"Pooled effect sizes from 105 articles (293 comparisons) indicated significant reductions in both primary and metastatic tumors.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},367446,1790524151,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":127,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},962084928432,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","OPEN ACCESS  \nCitation: Mirzaei Y, Hüffel M, McCann S, Bannach-Brown A, Tolba RH, Steitz J (2025) Animal models in preclinical metastatic breast cancer immunotherapy research: A systematic review and meta-analysis of efficacy outcomes. PLoS One 20(5): e0322876. [https://doi](https://doi). org/10.1371/journal.pone.0322876  \nEditor: Mohamed Abdelkarim, Faculty of Medicine of Tunis, TUNISIA  \nReceived: November 26, 2024  \nAccepted: March 28, 2025  \nPublished: May 7, 2025  \nCopyright: © 2025 Mirzaei et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.  \nData availability statement: The data and analytic code for this study are publicly available on the Open Science Framework at: [https://osf](https://osf). io/jhfy9 .  \nFunding: This study was funded by the Europäischer Fonds für regionale Entwicklung  \nRESEARCH ARTICLE  \nAnimal models in preclinical metastatic breast cancer immunotherapy research: A systematic review and meta-analysis of efficacy outcomes  \nYalda Mirzaei1, Martina Hüffel1, Sarah McCann2, Alexandra Bannach-Brown2, René H. Tolba1, Julia Steitz1*  \n1 Institute for Laboratory Animal Science, Uniklinik RWTH Aachen, Aachen, Germany, 2 Berlin Institute of Health at Charité (BIH), BIH QUEST Center for Responsible Research, Berlin, Germany  \n* [jsteitz@ukaachen.de](jsteitz@ukaachen.de)  \nAbstract  \nBreast cancer, particularly metastatic breast cancer (MBC), presents aggressive clinical challenges with limited treatment success. Immunotherapy has emerged asa promising approach, however, discrepancies between preclinical animal models and human cancers complicate translation to clinical outcomes. This systematic review and meta-analysis evaluated the effect of immunotherapy on primary and metastatic tumor regression in animal models of MBC and assessed the models’appropriateness and reproducibility to improve future preclinical study design. Following a preregistered protocol in PROSPERO (CRD42021207033), we conducted searches in MEDLINE, Embase, and Web of Science databases, yielding 2255 studies for title/abstract screening and 108 studies included after full-text screening. All included studies used mouse models, assessing primary outcomes through tumor volume or weight and metastatic outcomes via nodule count or bioluminescence. Only 14% of studies fully reported experimental animal characteristics, and 43% provided detailed experimental procedures. Of 105 articles (293 comparisons) included in the meta-analysis, pooled effect sizes indicated significant reductionsin both primary and metastatic tumors. However, high heterogeneity across studies and wide prediction intervals suggested substantial variability in model responses to immunotherapy. Univariable and multivariable meta-regressions failed to significantly explain this heterogeneity, suggesting additional factors may influence outcomes. Trim-and-fill and Egger’s regression tests indicated funnel plot asymmetry, implying potential publication bias and small study effects. While our analysis demonstrated positive effects of immunotherapy on MBC and highlighted variability in animal tumor models, addressing model-related heterogeneity and enhancing methodological transparency are essential to improve reproducibility and clinical translatability.  \nPLOS One | [https://doi.org/10.1371/journal.pone.0322876](https://doi.org/10.1371/journal.pone.0322876) May 7, 2025 1 / 19  \n(EFRE-0801767) and Bundesministerium für Bildung und Forschung (01KC2308A) . ABB is funded by the Volkswagen Stiftung ‘Impulsfür Wissenschaft’ grant. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.  \nCompeting interests: The authors have declared that no competing interests exist.  \nIntroduction  \nBreast cancer is the leading cause of","cbCaidmQ9AC4kQup","https://ap.wps.com/l/cbCaidmQ9AC4kQup","pdf",1348649,"English","# Abstract\n# Introduction","[{\"question\":\"What was the purpose of this systematic review and meta-analysis?\",\"answer\":\"To evaluate how immunotherapy affects primary and metastatic tumor regression in animal models of metastatic breast cancer, and to assess model appropriateness and reproducibility for improving future preclinical study design.\"},{\"question\":\"Which databases and study numbers were used in the review?\",\"answer\":\"Searches were conducted in MEDLINE, Embase, and Web of Science, yielding 2255 studies for title/abstract screening and 108 studies after full-text screening.\"},{\"question\":\"What did the meta-analysis find about immunotherapy efficacy?\",\"answer\":\"Pooled effect sizes from 105 articles (293 comparisons) indicated significant reductions in both primary and metastatic tumors.\"}]","Animal models in preclinical metastatic breast cancer immunotherapy research - A systematic review and meta-analysis of efficacy outcomes | PDF",1790170824,48,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1ef6c2d12529f23afddddc1211d65236.webp",983,1272,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f0b29c58dc348bf11c09a16f05c959b7.webp",982,1270,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8179470c76e52bf9e58ba563fb8be4c4.webp",981,1269,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/065efe22ba759bbb5aca07d32743cc21.webp",980,1268]